IMNM
Price
$16.51
Change
-$0.92 (-5.28%)
Updated
Nov 13 closing price
Capitalization
1.52B
125 days until earnings call
Intraday BUY SELL Signals
SRRK
Price
$30.07
Change
-$0.75 (-2.43%)
Updated
Nov 13 closing price
Capitalization
2.89B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs SRRK

Header iconIMNM vs SRRK Comparison
Open Charts IMNM vs SRRKBanner chart's image
Immunome
Price$16.51
Change-$0.92 (-5.28%)
Volume$1.91M
Capitalization1.52B
Scholar Rock Holding
Price$30.07
Change-$0.75 (-2.43%)
Volume$1.43M
Capitalization2.89B
IMNM vs SRRK Comparison Chart in %
View a ticker or compare two or three
VS
IMNM vs. SRRK commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and SRRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (IMNM: $16.51 vs. SRRK: $30.07)
Brand notoriety: IMNM and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 118% vs. SRRK: 53%
Market capitalization -- IMNM: $1.52B vs. SRRK: $2.89B
IMNM [@Biotechnology] is valued at $1.52B. SRRK’s [@Biotechnology] market capitalization is $2.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 5 bearish.
  • SRRK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а +6.52% price change this week, while SRRK (@Biotechnology) price change was +4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

SRRK is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($2.89B) has a higher market cap than IMNM($1.52B). IMNM YTD gains are higher at: 64.124 vs. SRRK (-28.690). IMNM has higher annual earnings (EBITDA): -187.92M vs. SRRK (-320.22M). SRRK has more cash in the bank: 295M vs. IMNM (268M). IMNM has less debt than SRRK: IMNM (4.14M) vs SRRK (61.5M). IMNM has higher revenues than SRRK: IMNM (12.6M) vs SRRK (0).
IMNMSRRKIMNM / SRRK
Capitalization1.52B2.89B52%
EBITDA-187.92M-320.22M59%
Gain YTD64.124-28.690-224%
P/E RatioN/AN/A-
Revenue12.6M0-
Total Cash268M295M91%
Total Debt4.14M61.5M7%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMSRRK
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
SRRK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVMSX29.730.08
+0.27%
JHancock Disciplined Value Mid Cap R2
WBIIX16.210.04
+0.25%
William Blair Instl International Gr
JVSNX16.080.02
+0.12%
Janus Henderson Small-Mid Cap Value N
MITEX17.36-0.03
-0.17%
Matthews Asia Innovators Institutional
PSGRX75.77-0.18
-0.24%
Putnam Small Cap Growth R

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.51%
IDYA - IMNM
57%
Loosely correlated
-0.19%
IPSC - IMNM
54%
Loosely correlated
N/A
NRIX - IMNM
54%
Loosely correlated
-5.37%
RLAY - IMNM
53%
Loosely correlated
-1.91%
VYGR - IMNM
53%
Loosely correlated
-0.23%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with NUVL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+0.10%
NUVL - SRRK
46%
Loosely correlated
+0.91%
IMNM - SRRK
46%
Loosely correlated
-0.51%
NRIX - SRRK
44%
Loosely correlated
-5.37%
CRNX - SRRK
43%
Loosely correlated
-0.28%
BDTX - SRRK
43%
Loosely correlated
+5.41%
More